{"id":568,"date":"2024-06-13T17:28:34","date_gmt":"2024-06-13T17:28:34","guid":{"rendered":"https:\/\/www.neolyspharma.ca\/member\/christian-roby\/"},"modified":"2026-07-31T22:49:51","modified_gmt":"2026-07-31T22:49:51","slug":"christian-roby","status":"publish","type":"member","link":"https:\/\/neolyspharma.ca\/en\/member\/christian-roby\/","title":{"rendered":"Christian Roby"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><br>Hailing from Quebec&nbsp;City, Christian Roby is a cofounder of Neolys&nbsp;Pharma, which he led as CEO from its founding in 2023 until 2026. He now sits on its board of directors and leads <a href=\"https:\/\/naralys.com\" target=\"_blank\" rel=\"noreferrer noopener\">Naralys Animal Health<\/a>. His bachelor\u2019s degree in pharmacy from Universit\u00e9&nbsp;Laval (1993) and his certificate in economics have allowed him to combine clinical pharmacy with entrepreneurship in his career. Roby spent nearly 9&nbsp;years working in a hospital in New&nbsp;Brunswick before returning to Quebec&nbsp;City to become the owner of two Uniprix pharmacies, which he managed for 13&nbsp;years.&nbsp;Following the sale of his pharmacies, he continued to work as a salaried pharmacist while becoming actively involved as a member of Anges&nbsp;Qu\u00e9bec, a venture capitalist network.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">As an angel investor, he has made nearly 20&nbsp;investments, becoming a shareholder in several highly promising start-ups, including Moka (acquired by Mogo&nbsp;Inc.), oxio (acquired by Cogeco&nbsp;Connexion), Puzzle&nbsp;Medical&nbsp;Devices, Polystyvert, and Zilia.<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_acf_changed":true},"categories":[25],"class_list":["post-568","member","type-member","status-publish","hentry","category-board-of-directors"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Christian Roby | Co-founder and Board Member, Neolys Pharma<\/title>\n<meta name=\"description\" content=\"Christian Roby, B. Pharm, cofounder of Neolys Pharma and board member, CEO of Naralys Animal Health.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/neolyspharma.ca\/en\/member\/christian-roby\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Christian Roby | Co-founder and Board Member, Neolys Pharma\" \/>\n<meta property=\"og:description\" content=\"Christian Roby, B. Pharm, cofounder of Neolys Pharma and board member, CEO of Naralys Animal Health.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/neolyspharma.ca\/en\/member\/christian-roby\/\" \/>\n<meta property=\"og:site_name\" content=\"Neolyspharma\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-31T22:49:51+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/neolyspharma.ca\\\/en\\\/member\\\/christian-roby\\\/\",\"url\":\"https:\\\/\\\/neolyspharma.ca\\\/en\\\/member\\\/christian-roby\\\/\",\"name\":\"Christian Roby | Co-founder and Board Member, Neolys Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/neolyspharma.ca\\\/en\\\/#website\"},\"datePublished\":\"2024-06-13T17:28:34+00:00\",\"dateModified\":\"2026-07-31T22:49:51+00:00\",\"description\":\"Christian Roby, B. Pharm, cofounder of Neolys Pharma and board member, CEO of Naralys Animal Health.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/neolyspharma.ca\\\/en\\\/member\\\/christian-roby\\\/#breadcrumb\"},\"inLanguage\":\"en-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/neolyspharma.ca\\\/en\\\/member\\\/christian-roby\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/neolyspharma.ca\\\/en\\\/member\\\/christian-roby\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/neolyspharma.ca\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Christian Roby\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/neolyspharma.ca\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/neolyspharma.ca\\\/en\\\/\",\"name\":\"Neolys Pharma\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/neolyspharma.ca\\\/en\\\/#organization\"},\"inLanguage\":\"en-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/neolyspharma.ca\\\/en\\\/#organization\",\"name\":\"Neolys Pharma inc.\",\"url\":\"https:\\\/\\\/neolyspharma.ca\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/neolyspharma.ca\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/neolyspharma.ca\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/neolys-logo.png\",\"contentUrl\":\"https:\\\/\\\/neolyspharma.ca\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/neolys-logo.png\",\"width\":512,\"height\":242,\"caption\":\"Neolys Pharma inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/neolyspharma.ca\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/neolys-pharma\"],\"legalName\":\"Neolys Pharma inc.\",\"telephone\":\"+1-418-931-2195\",\"email\":\"info@neolyspharma.ca\",\"description\":\"A biopharmaceutical company based in Qu\u00e9bec City, Neolys Pharma develops RM-581, a synthetic aminosteroid targeting poor-prognosis cancers.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Christian Roby | Co-founder and Board Member, Neolys Pharma","description":"Christian Roby, B. Pharm, cofounder of Neolys Pharma and board member, CEO of Naralys Animal Health.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/neolyspharma.ca\/en\/member\/christian-roby\/","og_locale":"en_US","og_type":"article","og_title":"Christian Roby | Co-founder and Board Member, Neolys Pharma","og_description":"Christian Roby, B. Pharm, cofounder of Neolys Pharma and board member, CEO of Naralys Animal Health.","og_url":"https:\/\/neolyspharma.ca\/en\/member\/christian-roby\/","og_site_name":"Neolyspharma","article_modified_time":"2026-07-31T22:49:51+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/neolyspharma.ca\/en\/member\/christian-roby\/","url":"https:\/\/neolyspharma.ca\/en\/member\/christian-roby\/","name":"Christian Roby | Co-founder and Board Member, Neolys Pharma","isPartOf":{"@id":"https:\/\/neolyspharma.ca\/en\/#website"},"datePublished":"2024-06-13T17:28:34+00:00","dateModified":"2026-07-31T22:49:51+00:00","description":"Christian Roby, B. Pharm, cofounder of Neolys Pharma and board member, CEO of Naralys Animal Health.","breadcrumb":{"@id":"https:\/\/neolyspharma.ca\/en\/member\/christian-roby\/#breadcrumb"},"inLanguage":"en-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/neolyspharma.ca\/en\/member\/christian-roby\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/neolyspharma.ca\/en\/member\/christian-roby\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/neolyspharma.ca\/en\/"},{"@type":"ListItem","position":2,"name":"Christian Roby"}]},{"@type":"WebSite","@id":"https:\/\/neolyspharma.ca\/en\/#website","url":"https:\/\/neolyspharma.ca\/en\/","name":"Neolys Pharma","description":"","publisher":{"@id":"https:\/\/neolyspharma.ca\/en\/#organization"},"inLanguage":"en-CA"},{"@type":"Organization","@id":"https:\/\/neolyspharma.ca\/en\/#organization","name":"Neolys Pharma inc.","url":"https:\/\/neolyspharma.ca\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/neolyspharma.ca\/en\/#\/schema\/logo\/image\/","url":"https:\/\/neolyspharma.ca\/wp-content\/uploads\/2026\/08\/neolys-logo.png","contentUrl":"https:\/\/neolyspharma.ca\/wp-content\/uploads\/2026\/08\/neolys-logo.png","width":512,"height":242,"caption":"Neolys Pharma inc."},"image":{"@id":"https:\/\/neolyspharma.ca\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/neolys-pharma"],"legalName":"Neolys Pharma inc.","telephone":"+1-418-931-2195","email":"info@neolyspharma.ca","description":"A biopharmaceutical company based in Qu\u00e9bec City, Neolys Pharma develops RM-581, a synthetic aminosteroid targeting poor-prognosis cancers."}]}},"_links":{"self":[{"href":"https:\/\/neolyspharma.ca\/en\/wp-json\/wp\/v2\/member\/568","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/neolyspharma.ca\/en\/wp-json\/wp\/v2\/member"}],"about":[{"href":"https:\/\/neolyspharma.ca\/en\/wp-json\/wp\/v2\/types\/member"}],"wp:attachment":[{"href":"https:\/\/neolyspharma.ca\/en\/wp-json\/wp\/v2\/media?parent=568"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/neolyspharma.ca\/en\/wp-json\/wp\/v2\/categories?post=568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}